Synnovis

We are Synnovis, a scientific organisation with a clinical purpose.

We work closely with our NHS partners to support the lives, health and wellbeing of patients.

Who we are

Synnovis is a pathology partnership between SYNLAB UK & Ireland, Guy’s and St Thomas’ NHS Foundation Trust, and King’s College Hospital NHS Foundation Trust. We bring together the very best in clinical, scientific and operational expertise to process blood and other diagnostic tests on behalf of organisations across the UK and internationally.

Learn more about us

Test database

We perform more than 1,500 diagnostic tests, spanning UK-leading nutrition testing to cutting-edge genetics. Our database provides details of each of these tests including how to order, sample specifications, turn-around-times and interpretation of results.

View

News & resources

Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients

NHS England became the world’s first health service to roll out circulating tumour DNA (ctDNA) testing for suspected lung cancer in 2025 Synnovis* have supported this initiative from its pilot phase and now provide ctDNA testing for over a third of eligible NHS patients in England including those from South London, Kent, Sussex, Surrey, West [...]

Synnovis supports development to dramatically reduce pre-transfusion testing times for myeloma patients

Validation work undertaken by Synnovis Biomedical Scientist, Molly Rutherford, has the potential to significantly improve the blood transfusion experience for patients receiving daratumumab, a treatment widely used for multiple myeloma. Multiple myeloma is the second most common blood cancer worldwide. Although it remains incurable, major advances in treatment have significantly improved patient outcomes, particularly following [...]

World Hepatitis Day initiative aims to detect undiagnosed blood borne viruses across South East London

To mark World Hepatitis Day on 28 July, Synnovis and NHS Trust colleagues in South East London are expanding routine blood testing in a one-day initiative to include screening for blood borne viruses, helping more people access early diagnosis and care. There are nearly two million new cases of hepatitis B and C each year. [...]